More News

25 Sep 2007 MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
25 Sep 2007 ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender
25 Sep 2007 Bristol-Myers Squibb to Acquire Adnexus Therapeutics
25 Sep 2007 Lundbeck in-licenses Circadin(R), a drug approved for the treatment of primary insomnia from Neurim Pharmaceuticals
25 Sep 2007 Array BioPharma and Celgene Corporation Announce Strategic Global R&D Collaboration
25 Sep 2007 Phase 3 Pivotal Trial of TOCOSOL(R) Paclitaxel Does Not Meet Primary Endpoint
25 Sep 2007 Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca
25 Sep 2007 Q-Med obtains approval for MACROLANETM VRF in Europe
22 Sep 2007 Exelixis Research Collaboration With Bristol-Myers Squibb Extended
22 Sep 2007 VIRxSYS Announces Acquisition of Intronn
21 Sep 2007 JDRF Partners With CoMentis for Diabetic Macular Edema Clinical Trial
21 Sep 2007 Taro Receives FDA Approvals for Ciclopirox Topical Solution, 8% (Nail Lacquer) and Grape Flavor Formulation of Loratadine Syrup, 5mg
20 Sep 2007 Alnylam Announces the Termination of its Collaboration with Merck & Co., Inc.
20 Sep 2007 Evotec to Acquire Renovis, Seek NASDAQ Listing
19 Sep 2007 LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies
19 Sep 2007 Antitope Announces Research Agreement with Fraunhofer Institute for Cell Therapy and Immunology
18 Sep 2007 A major pharmaceutical company has taken an exclusive option to BA058, a compound licensed by Ipsen to Radius in 2005
18 Sep 2007 Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
18 Sep 2007 Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan
18 Sep 2007 Celera Enters Oncology Research Collaboration with Merck to Develop Pharmacogenomic Tests
18 Sep 2007 Vasogen Plans Confirmatory Study of Celacade(TM) in Chronic Heart Failure to Support U.S. Regulatory Approval
15 Sep 2007 Study Shows Medtronic Neurostimulation Therapy Improves Chronic Neuropathic Leg and Back Pain
14 Sep 2007 Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
13 Sep 2007 Flamel Technologies Announces Medusa® License Agreement with Wyeth Pharmaceuticals
12 Sep 2007 Phosphagenics to commence Phase 2 TPM/Insulin cinical trial

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top